[DOI] [PMC free article] [PubMed] [Google Scholar] 103.Devries S., Dalen J.E., Eisenberg D.M., Maizes V., Ornish D., Prasad A., Sierpina V., Weil A.T., Willett W
These effects are usually mild and more typical at the start of treatment
How the Dose Is Gradually Increased Over Time Retatrutide was escalated stepwise from 2 mg to up to 12 mg once weekly over approximately 12 weeks or longer, depending on individual tolerability and trial protocol
CrossRef Assessing Mortality Disparities Among Non-Alcoholic Fatty Liver Disease Metabolic Dysfunction Fatty Liver Disease and Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Meta-Analysis Fahad Lakhdhir, Agha Syed Muhammad, Ahmed Nasir Qureshi, Imran A Shaikh, Imran Joher, Jawaria Majeed, Javaria Khan Cureus .2024;[Epub] CrossRef Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed Clinical and Molecular Hepatology .2024